As Pfiz­er/BioN­Tech prep EUA fil­ing for Covid-19 boost­er, FDA, CDC tell Amer­i­cans they don't need one just yet

As coro­n­avirus vari­ants threat­en to pro­long the Covid-19 pan­dem­ic and spur dis­cus­sions about vac­cine boost­ers, the FDA and CDC are send­ing a clear mes­sage: They are the ones with the fi­nal say on when and for whom those boost­ers are need­ed.

Pfiz­er and BioN­Tech plan to file for emer­gency au­tho­riza­tion for a third shot in the com­ing month, Pfiz­er CSO Mikael Dol­sten told Reuters on Thurs­day af­ter­noon, around the same time the com­pa­nies is­sued a state­ment high­light­ing re­al-world da­ta from Is­rael sug­gest­ing that vac­cine ef­fi­ca­cy in pre­vent­ing in­fec­tion and symp­to­matic dis­ease has de­clined six months post-vac­ci­na­tion. In a sep­a­rate me­dia in­ter­view, Der­rick Rossi, a co-founder of Mod­er­na, said boost­ers are “most like­ly go­ing to be in the cards.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER